Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer

Journal of Urology

Volumn 185, Issue 4, 2011, Pages 1497-1503

  Koike, Hidekazu ^a   Morikawa, Yasuyuki ^a   Sekine, Yoshitaka ^a   Matsui, Hiroshi ^a   Shibata, Yasuhiro ^a   Suzuki, Kazuhiro ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

calcitriol; cell proliferation; inhibitor of apoptosis proteins; prostate; prostatic neoplasms

Indexed keywords

CALCITRIOL; SMALL INTERFERING RNA; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN LNCAP; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HORMONE RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; TUMOR VOLUME;

CALCITRIOL; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 79952699414     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.005     Document Type: Article

References (25)

1. Brown AJ, Dusso A and Slatopolsky E: Vitamin D. Am J Physiol 1999; 277: 157.
2. Moffatt KA, Johannes WU, Hedlund TE et al: Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res 2001; 61: 7122.
3. Skowronski RJ, Peehl DM and Feldman D: Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 1993; 132: 1952.
4. Blutt SE, Polek TC, Stewart LV et al: A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res 2000; 60: 779.
5. Getzenberg RH, Light BW, Lapco PE et al: Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology 1997; 50: 999.
6. Gross C, Stamey T, Hancock S et al: Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). J Urol 1998; 159: 2035.
7. Beer T, Lemmon D, Lowe B et al: High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer 2003; 97: 1217.
8. Trump DL, Hershberger PA, Bernardi RJ et al: Anti-tumor activity of calcitriol: pre-clinical and clinical studies. J Steroid Biochem Mol Biol 2004; 89-90: 519.
9. Altieri DC and Marchisio PC: Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 1999; 79: 1327.
10. Zaffaroni N, Pennati M and Daidone MG: Survivin as a target for new anticancer interventions. J Cell Mol Med 2005; 9: 360.
11. Takai N, Miyazaki T, Nishida M et al: Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett 2002; 184: 105.
12. Dong Y, Sui L, Watanabe Y, Sugimoto K et al: Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 2002; 22: 2377.
13. Sarela AI, Macadam RC, Farmery SM et al: Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 2000; 46: 645.
14. Monzó M, Rosell R, Felip E et al: A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small cell lung cancers. J Clin Oncol 1999; 17: 2100.
15. Krajewska M, Krajewski S, Banares S et al: Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003; 9: 4914.
16. Kaur P, Kallakury BS, Sheehan CE et al: Survivin and Bcl-2 expression in prostatic adenocarcinomas. Arch Pathol Lab Med 2004; 128: 39.
17. Hayashi N, Asano K, Suzuki H et al: Adenoviral infection of survivin antisense sensitizes prostate cancer to etoposide in vivo. Prostate 2005; 65: 10.
18. Zhang M, Mukherjee N, Bermudez RS et al: Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo. Prostate 2005; 64: 293.
19. Olie RA, Simoes-Wust AP, Baumann B et al: A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 2000; 60: 2805.
20. Pennati M, Binda M, Colella G et al: Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Oncogene 2004; 23: 386.
21. Pennati M, Binda M, Colella G et al: Radiosensitization of human melanoma cells by ribozymemediated inhibition of survivin expression. J Invest Dermatol 2003; 120: 648.
22. Izquierdo M: Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther 2005; 12: 217.
23. Lifang Gao, Ling Zhang, Jiadi Hu et al: Downregulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Clin Cancer Res 2005; 11: 6333.
24. Wu SY, Putral LN, Liang M et al: Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use. Pharmacol Res 2009; 26: 512.
25. Li F, Ling X, Huang H et al: Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene 2005; 24: 1385.